封面
市場調查報告書
商品編碼
1593494

電子處方箋市場規模、佔有率和成長分析(按產品/服務、按交付方式、按物質、按應用、按最終用戶、按地區):行業預測 (2024-2031)

E-Prescribing Market Size, Share, Growth Analysis, By Product & Service (Solutions, Services), By Delivery Mode (Web- & Cloud-Based Solutions, On-Premises Solutions), By Substances, By Usage, By End User, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 178 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球電子處方箋市場規模為21億美元,從2023年的25.9億美元成長到2031年的139.3億美元,在預測期內(2024-2031年)預計複合年成長率為23.40。

由於 EPSC(受管制物質電子處方箋)的日益普及和有利的政府政策,全球電子處方箋市場正在顯著成長。此外,病患安全意識的增強正在刺激市場擴張。 COVID-19 大流行加速了電子處方箋的採用,因為醫療機構尋求最大限度降低感染風險的方法,並強調了更容易獲得處方藥的好處。電子處方箋允許醫療保健專業人員將處方箋直接髮送到藥房,將處方箋流程數位化,以提高準確性、減少錯誤並提高效率。它還可以與各種醫療保健系統無縫整合,促進及時獲得藥物並改善患者護理。這些因素共同推動了全球對電子處方箋解決方案的需求。

目錄

介紹

  • 分析目的
  • 定義
  • 市場範圍

分析方法

  • 資訊採購
  • 二手資料來源和主要資料來源
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 市場概況及展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 監管環境
  • 案例研究分析
  • 技術分析

電子處方箋市場:依產品/服務分類

  • 市場概況
  • 解決方案
    • 綜合解決方案
    • 獨立解決方案
  • 服務
    • 支援和維護服務
    • 實施服務
    • 網路服務
    • 培訓和教育服務

電子處方箋市場:以配送方式分類

  • 市場概況
  • 雲端基礎的解決方案
  • 本地解決方案

電子處方箋市場:依物質分類

  • 市場概況
  • 管制物質
  • 不受管制的物質

電子處方箋市場:按應用分類

  • 市場概況
  • 手持裝置
  • 基於電腦的設備

電子處方箋市場:依最終用戶分類

  • 市場概況
  • 醫院
  • 在診所工作的醫生
  • 藥局

電子處方箋市場:按地區

  • 市場概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲 (MEA)
    • 波灣合作理事會(GCC) 國家
    • 南非
    • 其他中東/非洲

競爭格局

  • 前5名企業對比
  • 主要企業市場定位(2023年)
  • 主要市場參與者所採取的策略
  • 近期市集活動
  • 主要企業市場佔有率(2023年)

主要企業簡介

  • Epic系統公司(美國)
  • Surescripts-Rxhub, LLC(美國)
  • 亨利沙因公司(美國)
  • DRFIRST, Inc.(美國)
  • DrChrono(美國)
  • MDToolbox(美國)
  • eClinicalWorks(美國)
  • 復興健康(美國)
  • Moderna Therapeutics(美國)
  • MediMobile(美國)
  • ePrescribeRx(美國)
  • 健康波(美國)
  • RxNT(美國)
  • DrChrono(美國)
  • MediLedger 網路(美國)
  • Sunknowledge 服務公司(美國)
  • PointClickCare(加拿大)
  • RxVantage(美國)
簡介目錄
Product Code: SQMIG35F2016

Global E-Prescribing Market size was valued at USD 2.1 billion in 2022 and is poised to grow from USD 2.59 billion in 2023 to USD 13.93 billion by 2031, growing at a CAGR of 23.40% during the forecast period (2024-2031).

The global e-prescribing market is experiencing significant growth, driven by the rising adoption of electronic prescribing for controlled substances (EPSC) and favorable government policies. Additionally, growing awareness of patient safety is further fueling market expansion. The COVID-19 pandemic accelerated the adoption of e-prescribing as healthcare facilities sought ways to minimize infection risks, highlighting the benefits of easier access to prescription medications. E-prescribing, which enables medical professionals to send prescriptions directly to pharmacies, improves accuracy, reduces errors, and enhances efficiency by digitizing the prescription process. It also ensures seamless integration with various medical systems, facilitating timely medication access and improving patient care. These factors collectively contribute to the growing demand for e-prescribing solutions worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global E-Prescribing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global E-Prescribing Market Segmental Analysis

Global E-Prescribing Market is segmented by Product & Service, Delivery Mode, Substances, Usage, End User, and Region. Based on Product & Service, the market is segmented into Solutions, and Services. Based on Delivery Mode, the market is segmented into Web- & Cloud-Based Solutions, and On-Premises Solutions. Based on Substances, the market is segmented into Controlled Substances, and Non-Controlled Substances. Based on Usage, the market is segmented into Handheld Devices, and Computer-Based Devices. Based on End User, the market is segmented into Hospitals, Office-Based Physicians, and Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global E-Prescribing Market

The growing government support for the adoption of Electronic Health Record (EHR) solutions, combined with the rising need to manage escalating healthcare costs, is a key driver for the global E-Prescribing market. The integration of EHR systems has significantly improved prescription management by enhancing the accessibility of patient medical histories, offering more comprehensive data than standalone e-prescribing systems. This seamless flow of information has streamlined the prescription process, boosting efficiency and reducing errors. As a result, there is an increasing demand for e-prescribing solutions that can leverage EHR systems to improve patient care and optimize healthcare workflows, further driving market growth.

Restraints in the Global E-Prescribing Market

One of the primary restraints hindering the growth of the global E-Prescribing market is the high cost associated with the implementation and maintenance of e-prescribing systems integrated with Electronic Health Records (EHR). The expense involved in adopting such solutions poses a significant challenge, particularly in developing economies where budget constraints and limited healthcare IT infrastructure further impede adoption. These regions struggle to implement advanced technological solutions due to the financial burden and lack of adequate support, preventing the widespread adoption of e-prescribing systems. As a result, the growth of the market is slowed, especially in emerging economies that face these infrastructural and economic challenges.

Market Trends of the Global E-Prescribing Market

One of the key trends driving the growth of the global e-prescribing market is the increasing opioid crisis in the United States. The e-prescribing of controlled substances (EPCS) system provides a secure and transparent solution, reducing the potential for misuse and fraud. By implementing electronic prescriptions for controlled medications, healthcare providers can more easily and safely prescribe necessary drugs to patients who genuinely need them, while simultaneously mitigating the risks associated with prescription drug abuse. This shift towards digital prescriptions is seen as an effective strategy to combat the opioid epidemic, promoting both patient safety and regulatory compliance, thus accelerating the adoption of e-prescribing technologies across the healthcare sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Regulatory Landscape
  • Case Study Analysis
  • Technology Analysis

E-Prescribing Market by Product & Service

  • Market Overview
  • Solutions
    • Integrated Solutions
    • Standalone Solutions
  • Services
    • Support & Maintenance Services
    • Implementation Services
    • Network Services
    • Training & Education Services

E-Prescribing Market by Delivery Mode

  • Market Overview
  • Web- & Cloud-Based Solutions
  • On-Premises Solutions

E-Prescribing Market by Substances

  • Market Overview
  • Controlled Substances
  • Non-Controlled Substances

E-Prescribing Market by Usage

  • Market Overview
  • Handheld Devices
  • Computer-Based Devices

E-Prescribing Market by End User

  • Market Overview
  • Hospitals
  • Office-Based Physicians
  • Pharmacies

E-Prescribing Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Epic Systems Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Surescripts-Rxhub, LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Henry Schein, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DRFIRST, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DrChrono (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MDToolbox (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • eClinicalWorks (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Renaissance Health (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Moderna Therapeutics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MediMobile (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ePrescribeRx (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HealthWave (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RxNT (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DrChrono (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MediLedger Network (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sunknowledge Services Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PointClickCare (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RxVantage (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments